Controlling chronic TTP

2005BloodImmunology and Microbiology被引 3开放获取

摘要

Comment on Fakhouri et al, page [1932][1] For patients who have thrombotic thrombocytopenic purpura (TTP) associated with acquired severe ADAMTS13 deficiency, rituximab may be effective for helping to establish remission and prevent recurrence. The effectiveness of plasma exchange treatment for

引用本文（GB/T 7714）

James N. George. Controlling chronic TTP[J]. Blood, 2005.

引文网络

参考文献与被引分析加载中…

DOI：https://doi.org/10.1182/blood-2005-06-2535

本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。